Accedi
Accedi
Oppure accedi con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registrati
Oppure accedi con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Home
  2. Azioni
  3. Canada
  4. Bourse de Toronto
  5. Kane Biotech Inc.
  6. Notizie
  7. Altre lingue
    KNE   CA4838092084

KANE BIOTECH INC.

(KNE)
Tempo differito Bourse de Toronto  -  16:43:18 03/02/2023
0.1100 CAD   -8.33%
04/01Kane Biotech annuncia il primo accordo di distribuzione per il suo idrogel antimicrobico Coactiv+
MT
04/01Kane Biotech Inc. Annuncia il primo accordo di distribuzione per l'idrogel antimicrobico coactiv+™.
CI
2022Transcript : Kane Biotech Inc., Q3 2022 Earnings Call, Nov 24, 2022
CI
RiassuntoQuotazioniGraficiNotizieCalendarioSocietàFinanzaDerivatiFondi 
RiassuntoTutte le notizieAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su KANE BIOTECH INC.
16/01Kane Biotech: DermaKB™ Offers Personalized Scalp Solutions Developed by Kane Biotec..
04/01Kane Biotech Announces First Distribution Agreement for its Coactiv+ Antimicrobial Hydr..
04/01Kane Biotech Announces First Distribution Agreement for its coactiv+™ Antimicrobi..
04/01Kane Biotech Inc. Announces First Distribution Agreement for coactiv+™ Antimicrobi..
2022Kane Biotech Inc. Reaches an Agreement to Obtain Loans in the Aggregate Amount of $2,00..
2022Kane Biotech Announces Loan Transaction
2022Kane Biotech Third-Quarter Loss Narrows on Higher Sales and Lower Expenses
2022Kane Biotech Announces Third Quarter 2022 Financial Results
2022Kane Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended ..
2022Kane Biotech to Release Third Quarter 2022 Financial Results on November 24, 2022 &nda..
2022Kane Biotech Announces 510 Submission for its coactiv+ Antimicrobial Hydrogel
2022Kane Biotech Announces 510(k) Submission for its coactiv+™ Antimicrobial Hydrogel
2022Kane Biotech Inc. Announces 510(K) Submission for Its Coactiv+™ Antimicrobial Hydr..
2022Kane Biotech to Present at Symposium on Advanced Wound Care Fall Forum
2022Kane Biotech Receives an Additional $425K USD of Funding for its DispersinB® Hydrogel f..
2022Kane Biotech: Three and six months ended June 30, 2022
2022Kane Biotech: Three and six months ended June 30, 2022
2022Kane Biotech Announces Second Quarter 2022 Financial Results
2022Kane Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended ..
2022Kane Biotech to Release Second Quarter 2022 Financial Results on August 25, 2022 &ndash..
2022Kane Biotech Announces Adoption of Amended and Restated Stock Option Plan and Performan..
2022Kane Biotech Announces Amended Credit Facility
2022Kane Biotech Inc. Announces Amended Credit Facility
2022Kane Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
2022Kane Biotech First-Quarter Loss Widens as Sales Rise by 50%
2022Kane Biotech Announces First Quarter 2022 Financial Results
2022Kane Biotech to Release First Quarter 2022 Financial Results on May 26 - Conference Cal..
2022Kane Biotech to Release First Quarter 2022 Financial Results on May 26 – Conferen..
2022Kane Biotech Obtains ISO 13485 Certification
2022Kane Biotech Announces Closing of Private Placement
2022Kane Biotech Obtains ISO 13485 Certification
2022Kane Biotech Inc. announced that it has received CAD 1 million in funding
2022Kane Biotech Announces Update on Private Placement
2022Kane Biotech Provides Update on $1 Million Private Placement
2022Kane Biotech Reports Extension of Private Placement
2022Kane Biotech: Three Months and Full Year Ended December 31, 2021
2022Kane Biotech Inc. - STEM Animal Health Awarded Veterinary Oral Health Council Seal of A..
2022STEM Animal Health Awarded Veterinary Oral Health Council Seal of Acceptance for Pet Or..
2022IIROC Trading Resumption - KNE
2022STEM Animal Health Awarded Veterinary Oral Health Council (VOHC) Seal of Acceptance for..
2022IIROC Trading Halt - KNE
2022Kane Biotech Appoints Dr. Gregory Schultz as Chief Scientific Officer
2022Kane Biotech Appoints Dr. Gregory Schultz as Chief Scientific Officer
2022Kane Biotech Inc. Appoints Dr. Gregory Schultz as Chief Scientific Officer
2022Kane Biotech: Biofilm Research Leads to Folliculitis Relief
2022Kane Biotech Fourth-Quarter Loss Widens as Higher Costs Offset Sales Gains
2022Kane Biotech Brief: Cash at December 31, 2021 was $1,153,090 Vs $1,00..
2022Kane Biotech Brief: Loss for Q4 2021 was $(1,257,173) Vs $(945,795) f..
2022Kane Biotech Brief: Total Revenue for Q4 was $411,693, an increase of..
2022Kane Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
2022Kane Biotech Announces Fourth Quarter and Full Year 2021 Financial Results
2022Kane Biotech Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 20..
2022Kane Biotech Inc. Auditor Raises 'Going Concern' Doubt
2022Kane Biotech Completes Safety and Biocompatibility Studies for DispersinB Wound Gel in ..
2022Kane Biotech Successfully Completes Safety and Biocompatibility Studies for DispersinB®..
2022Kane Biotech Successfully Completes Safety and Biocompatibility Studies for DispersinB ..
2022Kane Biotech to Release Fourth Quarter and Full Year 2021 Financial Results on March 24..
2022Kane Biotech Announces Private Placement Offering
2022Kane Biotech Inc. announced that it expects to receive CAD 1 million in funding
2022Kane Biotech: Personal DermaKB™ Stories Meet Rina Grasman
2022Kane Biotech Announces New Collaboration Agreements for Prosthetic Joint Infection, Exp..
2022Kane Biotech Announces New Collaboration Agreements for Prosthetic Joint Infection, Exp..
2022Kane Biotech Announces New Collaboration Agreements for Prosthetic Joint Infection, exp..
2022Kane Biotech Says Wound Care Commercialization to be Key Company Focus in 2022
2022Wound Care Commercialization to be a Key Company Focus in 2022
2021Kane Biotech: Three and Nine Months Ended September 30, 2021
2021Kane Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended ..
2021Kane Biotech Third-Quarter Loss Widens Despite Sales Gain
2021Kane Biotech Announces Third Quarter 2021 Financial Results
2021Kane Biotech to Release Third Quarter 2021 Financial Results on November 16 – Con..
2021Kane Biotech Announces New Credit Facility
2021Kane Biotech Inc. Announces New Credit Facility
2021Kane Biotech : STEM Animal Health Completes First Shipment of Bluestem Oral..
2021STEM Animal Health completes first shipment of bluestem™ oral care products to Pe..
2021Kane Biotech Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
2021Kane Biotech: Announces Second Quarter 2021 Financial Results
2021Kane Biotech: to Release Second Quarter 2021 Financial Results on August 26 – Confe..
2021Kane Biotech : Expands Wound Care and Surgical Portfolio With Antimicrobial..
2021Kane Biotech: Expands its Wound Care and Surgical Portfolio with a coactiv+TM Antimicrobi..
2021Kane Biotech Inc. Expands its Wound Care and Surgical Portfolio with a coactiv+TM Antim..
2021Kane Biotech: Announces Cancellation of Options and Issuance of Restricted Share Units
2021Kane Biotech : Announces Key Milestones as Wound Care Project Advances to H..
2021Kane Biotech announces two key milestones as DispersinB® wound care project advances to..
2021Kane Biotech Inc. Prepares its First Batch of DispersinB®
2021Kane Biotech Inc. Announces New Manufacturing Partnership with Dow Development Laborato..
2021Kane Biotech to meet investors at Whistler 2021 Capital Conference
2021Kane Biotech launches 2021 business update series
2021Kane Biotech Announces Adoption of Performance and Restricted Share Unit Plan and Amend..
2021Kane Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
2021Kane Biotech : First Quarter Loss Narrows Despite Sales Drop
2021Kane Biotech Announces First Quarter 2021 Financial Results
2021Kane Biotech : Announces "Strong Positive Results" of DermaKB Shampoo Consu..
2021Kane Biotech Announces Strong Positive Results of DermaKB™ Shampoo Consumer Trial
2021Kane Biotech Inc. Announces Strong Positive Results of DermaKB™ Shampoo Consumer Trial
2021Kane Biotech Strengthens Board with Biotech Executive
2021Kane Biotech Appoints Allan Mandelzys as an Advisor to Board of Directors
2021Kane Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2020
2021Kane Biotech Fourth-Quarter Loss Narrows Even as Revenue Falls 54%
2021Kane Biotech Announces Fourth Quarter and Full Year 2020 Financial Results
2021Kane Biotech Inc. Auditor Raises 'Going Concern' Doubt